O. Univ.-Prof. Dr. med. univ. Georg Stingl - Haut- und Geschlechtskrankheiten, Wien - Publikationen

G. Stingl, E.C. Wolff-Schreiner, W.J. Pichler, F. Gschnait, W. Knapp, K. Wolff:
Epidermal Langerhans cells bear Fc and C3 receptors.
Nature, 268: 245-246, 1977

G. Stingl, S.I. Katz, L. Clement, I. Green, E.M. Shevach:
Immunologic functions of Ia-bearing epidermal Langerhans cells.
Journal of Immunology, 121: 2005-2013, 1978

E. Tschachler, G. Schuler, J. Hutterer, H. Leibl, K. Wolff, G. Stingl:
Expression of Thy-1 antigen by murine epidermal cells.
Journal of Investigative Dermatology, 81: 282-285, 1983

G. Stingl, F. Koning, H. Yamada, W.M. Yokoyama, E. Tschachler, J.A. Bluestone, G. Steiner, L.E. Samelson, A.M. Lew, J.E. Coligan, E.M. Shevach:
Thy-1+ dendritic epidermal cells express T3 antigen and the T-cell receptor * chain.
Proceedings of the National Academy of Sciences U.S.A., 84: 4586-4590, 1987

B. Wang, A. Rieger, O. Kilgus, K. Ochiai, D. Maurer, D. Födinger, J.P. Kinet, G. Stingl:
Epidermal Langerhans cells from normal human skin bind monomeric IgE
via Fc*RI.
Journal of Experimental Medicine, 175: 1353-1365, 1992

E. Fiebiger, D. Maurer, H. Holub, B. Reininger, G. Hartmann, M. Woisetschläger, J.P.Kinet, G. Stingl:
Serum IgG autoantibodies directed against the  chain of FcRI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?
Journal of Clinical Investigation, 96: 2606-2612, 1995

R. Valenta, D. Maurer, R. Steiner, S. Seiberler, W.R. Sperr, P. Valent, S. Spitzauer, S. Kapiotis, J. Smolen, G. Stingl:
Immunoglobulin E response to human proteins in atopic patients.
Journal of Investigative Dermatology, 107: 203-208, 1996

S. Schreiber, E. Kämpgen, E. Wagner, D. Pirkhammer, J. Trcka, H. Korschan, A. Lindemann, R. Dorfner, H. Kittler, F. Kastelnik, Z. Küpcü, A. Sinski, K. Zatloukal, M. Buschle, W. Schmidt, M. Birnstiel, R.E. Kempe, T. Voigt, H.A. Weber, H. Pehamberger, R. Mertelsmann, E.B. Bröcker, K. Wolff, G. Stingl:
Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I study.
Human Gene Therapy, 10: 983-993, 1999

G. Stary, C. Bangert, M. Tauber, R. Strohal, T. Kopp, G. Stingl
Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells.
The Journal of Experimental Medicine, 204: 1441-1451, 2007

G. Stary, I. Klein, W. Bauer, F. Koszik, B. Reininger, S. Kohlhofer, K. Gruber, H. Skvara,
T. Jung, G. Stingl:
Glucocorticosteroids modify Langerhans cells to produce TGF-β and expand regulatory T cells.
Journal of Immunology, 186: 103-112, 2011

N. Romani, P. Brunner, G. Stingl:
Changing views of the role of Langerhans cells.
Journal of Investigative Dermatology, 132: 872-881, 2012

M.C. Brüggen, I. Klein, H. Greinix, W. Bauer, Z. Kuzmina, W. Rabitsch, P. Kalhs,
P. Petzelbauer, R. Knobler, G. Stingl, G. Stary:
Diverse T cell responses characterize the different manifestations of cutaneous graft-versus-host disease.
Blood, 123: 290-299, 2014